Benefits from Adding the 5-Lipoxygenase Inhibitor Zileuton to Conventional Therapy in Aspirin-intolerant Asthmatics (Q74490010)
Jump to navigation
Jump to search
scientific article published on 01 April 1998
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Benefits from Adding the 5-Lipoxygenase Inhibitor Zileuton to Conventional Therapy in Aspirin-intolerant Asthmatics |
scientific article published on 01 April 1998 |
Statements
Benefits from adding the 5-lipoxygenase inhibitor zileuton to conventional therapy in aspirin-intolerant asthmatics (English)
Benefits from Adding the 5-Lipoxygenase Inhibitor Zileuton to Conventional Therapy in Aspirin-intolerant Asthmatics (English)
1 reference
A Szczeklik
L Mastalerz
G Bochenek
E Nizankowska
B. Dahlén
E. Nizankowska
O. Zetterström
M. Kumlin
G. Pinis
L. J. Swanson
T. I. Boodhoo
S. Wright
L. M. Dubé
1 April 1998
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference